Biocartesian
Summer 2024Converting biology into digital molecular maps
Hard TechB2BBiotechDiagnosticsDrug discovery
About Company
Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.
